Stay updated with breaking news from Nasdaq Ocup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Free Report) CFO Nirav S. Jhaveri purchased 10,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were purchased at an average price of $2.10 per share, with a total value of $21,000.00. Following the completion of the purchase, the chief financial officer now […]
FARMINGTON HILLS, Mich., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company...
Tucker Asset Management LLC acquired a new position in shares of Ocuphire Pharma, Inc. (NASDAQ:OCUP – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 29,106 shares of the company’s stock, valued at approximately $126,000. Tucker Asset Management LLC owned […]
Ocuphire Pharma (NASDAQ:OCUP – Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.01), MarketWatch Earnings reports. The firm had revenue of $3.67 million during the quarter. Ocuphire Pharma Trading Up 1.9 % Ocuphire Pharma stock opened at $4.22 […]
Ocuphire Pharma (NASDAQ:OCUP – Get Free Report) issued its quarterly earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.01), MarketWatch Earnings reports. The business had revenue of $3.67 million during the quarter. Ocuphire Pharma Stock Up 1.9 % Shares of OCUP […]